Early access to compounded GLP-1 medications prevents progression of metabolic dysfunction and reduces lifetime healthcare costs from obesity-related comorbidities like type 2 diabetes, hypertension, and cardiovascular disease
Fridays takes a broader approach by including personalized dietitian coaching and group sessions
Common early effects may include: Reduced appetite or earlier fullness Less interest in snacking Mild nausea, especially after injections Temporary fatigue These symptoms are usually strongest early on and tend to improve as the body adjusts
GSH levels positively correlate with those of active vitamin D (Jain et al., 2014), whose deficiency has been shown to play a detrimental role in COVID-19 (Grant et al., 2020
Ultimately, treatment decisions should be individualized based on a patients overall health, risks, and goals